From: Genetic variations in PRKAA1 predict the risk and progression of gastric Cancer
Genotype | Controls, n (%) | Patients, n (%) | OR (95% CI)a | p-Value |
---|---|---|---|---|
rs10074991 | ||||
AA | 128(26.12) | 104(21.62) | Reference | |
AG | 261(53.27) | 255(53.01) | 1.19(0.87,1.62) | 0.283 |
GG | 101(20.61) | 122(25.36) | 1.44(0.99,2.09) | 0.056 |
AG/GG | 362(73.88) | 377(78.38) | 1.26(0.94,1.70) | 0.127 |
Additive model | 1.21(1.01, 1.46) | 0.042 | ||
rs13361707 | ||||
TT | 129(26.33) | 103(21.41) | Reference | |
TC | 260(53.06) | 256(53.22) | 1.22(0.89,1.66) | 0.219 |
CC | 101(20.61) | 122(25.36) | 1.47(1.01,2.14) | 0.043 |
TC/CC | 361(73.67) | 365(75.88) | 1.29(0.96,1.74) | 0.093 |
Addictive model | 1.22(1.02,1.47) | 0.033 | ||
rs154268 | ||||
TT | 297(60.61) | 271(56.34) | Reference | |
TC | 176(35.92) | 179(37.21) | 1.13(0.86,1.47) | 0.388 |
CC | 17(3.47) | 31(6.44) | 1.96(1.06,3.63) | 0.033 |
TC/CC | 193(39.39) | 210(43.66) | 1.20(0.93,1.56) | 0.158 |
Additive model | 1.24(1.00,1.53) | 0.053 | ||
rs6882903 | ||||
CC | 342(69.80) | 312(64.86) | Reference | |
CA | 134(27.35) | 149(30.98) | 0.86(0.41,1.80) | 0.687 |
AA | 14(2.86) | 20(4.16) | 1.56(0.77,3.15) | 0.217 |
CA/AA | 148(30.20) | 169(35.14) | 1.26(0.96,1.65) | 0.097 |
Additive model | 1.23(0.98,1.55) | 0.078 | ||
rs3805490 | ||||
TT | 279(56.94) | 280(58.21) | Reference | |
TA | 181(36.94) | 170(35.34) | 0.93(0.71,1.21) | 0.567 |
AA | 30(6.12) | 31(6.44) | 1.02(0.60,1.73) | 0.953 |
TA/AA | 211(43.06) | 201(41.79) | 0.94(0.73,1.21) | 0.627 |
Additive model | 0.97(0.79,1.19) | 0.756 | ||
rs461404 | ||||
AA | 298(60.82) | 270(56.13) | Reference | |
GA | 175(35.71) | 179(37.21) | 1.14(0.87,1.49) | 0.341 |
GG | 17(3.47) | 32(6.65) | 2.05(1.11,3.78) | 0.022 |
GA/GG | 192(39.18) | 211(43.87) | 1.22(0.95,1.58) | 0.125 |
Additive model | 1.26(1.01,1.56) | 0.037 |